(Q80066469)

English

Posaconazole

scientific article published on 01 March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Posaconazole (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Peter Kirkpatrick

4

object named as

Peter Kirkpatrick

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Carol A Kauffman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Anurag N Malani

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Chris Easley

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 March 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

183-184

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

https://scigraph.springernature.com/pub.10.1038/nrd2270

0 references

Clinical efficacy of new antifungal agents

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Posaconazole: a broad-spectrum triazole antifungal

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Antifungal agents: mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5].

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Zygomycosis: reemergence of an old pathogen

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Posaconazole as salvage therapy for zygomycosis

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Refractory coccidioidomycosis treated with posaconazole

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Voriconazole: a new triazole antifungal agent

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNRD2270

31 March 2020

Identifiers

10.1038/NRD2270

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17396290%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80066469&oldid=1988197413"